Institutional investors purchased a net $1.1 million shares of PTX during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 25.73% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
| Individual stakeholders | 45.27% |
| Mutual fund holders | 4.78% |
| Other institutional | 20.95% |